| Patient | Ronald Reagan |
|---|---|
| Date of birth | 1936-02-06 |
| Identifiers | MRN HR-ML008-SYN; SSN (made up) 000-08-6047 |
| Document date | 2026-02-10 |
| Author | Margaret Ellison, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for primary care visit one month after right hip fracture repair, with dementia and caregiver assessment. [S]
Hemoglobin: 11.1 g/dL (low); Sodium: 137 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.12 mg/dL; eGFR: 61 mL/min/1.73 m²; Glucose: 96 mg/dL; Calcium: 9 mg/dL; 25-hydroxyvitamin D: 16 ng/mL (low); Intact PTH: 78 pg/mL (high); Alkaline phosphatase: 134 U/L (high); Magnesium: 2 mg/dL; TSH: 2.3 mIU/L; MoCA: 11; Barthel Index: 55; GDS-15: 4. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-10 | Body height | 185 | cm | S |
| 2026-02-10 | Body weight | 76 | kg | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 2026-02-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-02-10 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-02-10 | Heart rate | 64 | /min | S |
| 2026-02-10 | Respiratory rate | 16 | /min | S |
| 2026-02-10 | Body temperature | 36.6 | Cel | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-10 | Hemoglobin [Mass/volume] in Blood | 11.1 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-02-10 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-02-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 61 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-02-10 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-02-10 | Calcium [Mass/volume] in Serum or Plasma | 9 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-02-10 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 16 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-02-10 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 78 | pg/mL | 15-65 pg/mL | High | S |
| 2026-02-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 134 | U/L | 40-129 U/L | High | S |
| 2026-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.4 mg/dL | Normal | S |
| 2026-02-10 | Thyrotropin [Units/volume] in Serum or Plasma | 2.3 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-02-10 | Total score [MoCA] | 11 | {score} | S | ||
| 2026-02-10 | Total score Barthel Index | 55 | {score} | S | ||
| 2026-02-10 | Geriatric depression scale (GDS) short version total | 4 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Donepezil 10 mg oral tablet, one tablet by mouth daily in the morning | One tablet by mouth daily in the morning | Oral route | 2022-03-07 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets (1,000 mg) by mouth three times daily | Two tablets by mouth three times daily | Oral route | 2026-01-14 to 2026-04-14 | completed | S |
| Oxycodone 5 mg oral tablet, one tablet by mouth every six hours as needed for severe pain | One tablet by mouth every six hours as needed for severe pain | Oral route | 2026-01-14 to 2026-02-10 | stopped | S |
| Diphenhydramine 25 mg oral capsule, one capsule by mouth at bedtime | One capsule by mouth at bedtime | Oral route | 2026-01-16 to 2026-02-10 | stopped | S |
| Enoxaparin 40 mg/0.4 mL prefilled syringe, inject 40 mg under the skin daily through day 35 after surgery | Inject 40 mg under the skin once daily | Subcutaneous route | 2026-01-14 to 2026-02-17 | completed | S |
| Cholecalciferol 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-10 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alzheimer's disease with late onset, disclosed in 1994 | active | confirmed | G30.1 | S — Synthetic modern coding of the publicly disclosed diagnosis. |
| Dementia due to Alzheimer's disease, moderate (FAST stage 5), with evening restlessness | active | confirmed | F02.B0 | S — Synthetic stage; his actual stage at this age was not made public. |
| Osteoporosis with right hip fragility fracture after a fall at home, repaired with internal fixation; subsequent care | active | confirmed | M80.051D | S — Synthetic modern coding of the documented January 2001 hip fracture as an osteoporotic fracture; bone density and fracture pattern are synthetic. |
| Vitamin D deficiency | resolved | confirmed | E55.9 | S — Synthetic finding from the first-visit 25-hydroxyvitamin D; repleted by three months. |
| Acute blood loss anemia after hip surgery | resolved | confirmed | D62 | S — Synthetic postoperative finding; resolved by three months. |
| History of falling | active | confirmed | Z91.81 | S — Synthetic modern coding linked to the documented fall. |
| Personal history of colon cancer, operated on in 1985 | active | confirmed | Z85.038 | S — Synthetic modern coding of the documented 1985 operation. |